Psychedelic Research in
Turkey
Blossom currently tracks 9 psychedelic clinical trials connected to Turkey. The country page also links to 2 stakeholders, giving the page ecosystem context beyond registered studies.
Key Insights
A concise read of the policy, research, and stakeholder signals shaping psychedelic medicine in Turkey.
- 1
Blossom tracks 9 psychedelic clinical trials connected to Turkey, with none currently marked active.
- 2
Visible trial compounds include Esketamine and Ketamine.
- 3
Visible trial topics include Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD) and Depressive Disorders.
- 4
The country page links to 2 stakeholders in Blossom's ecosystem data.
- 5
The country access guide currently classifies access as "Medical Only (Private)"; details vary by compound and care setting.
Research Snapshot
Blossom currently tracks 9 psychedelic clinical trials connected to Turkey.
- Active trials
- 0
- Total trials
- 9
- Stakeholders
- 2
- Events
- 0
None marked active
Country-linked records
Linked organisations
No linked events
Top Compounds
- Esketamine(5)
- Ketamine(4)
Top Study Topics
- Major Depressive Disorder (MDD)(4)
- Treatment-Resistant Depression (TRD)(3)
- Depressive Disorders(1)
- Peripartum(1)
Medical Access Snapshot
Turkey maintains a restrictive national control regime for classical serotonergic and empathogenic psychedelics: most tryptamines, phenethylamines and classic psychedelic plants/ preparations are scheduled and not available outside authorised research or prosecution exceptions. Medical use of ketamine as an anaesthetic and analgesic is well established in Turkish clinical practice; esketamine (marketed as SPRAVATO in some markets) appears in Turkish product information sources but is not known to be broadly reimbursed by the public social security system...
Regulatory Status
The linked medical access and reimbursement guide summarises Turkey as "Medical Only (Private)". Turkey maintains a restrictive national control regime for classical serotonergic and empathogenic psychedelics: most tryptamines, phenethylamines and classic psychedelic plants/ preparations are scheduled and not available outside authorised research or prosecution exceptions. Medical use of ketamine as an anaesthetic and analgesic is well established in Turkish clinical practice; esketamine (marketed as SPRAVATO in some markets) appears in Turkish product information sources but is not known to be broadly reimbursed by the public social security system (SGK) and is administered under specialist supervision.
Country Details
- Region
- Asia
- Last updated
- 4 May 2026
Country Report
Medical Only (Private)Medical Access and Reimbursement
Turkey maintains a restrictive national control regime for classical serotonergic and empathogenic psychedelics: most tryptamines, phenethylamines and classic psychedelic plants/ preparations are scheduled and not available outside authorised research or prosecution exceptions. Medical use of...
Open access guide →Psychedelic Stakeholders in Turkey
Organisations, sponsors, clinics, and research groups connected to psychedelic science in Turkey.
Clinical Trials
Active and completed clinical trials investigating psychedelic-assisted therapies in Turkey.